Pro 2013-018 (Jianfeng Group's 2013 Corporate Bond Issuance Announcement)-1
Release time:
2020-08-05
Securities Code: 600668 Securities Abbreviations: Jianfeng Group Announcement Number: Pro 20 13 - 018
Zhejiang Jianfeng Group Co., Ltd. 20 13 Corporate Bonds (Phase I)
Issue Announcement
Sponsor (Lead Underwriter): zheshang Securities Co., Ltd.
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of announcement , and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Important Note
, Zhejiang Jianfeng Group Co., Ltd. (hereinafter referred to as "Issuer", "Company" or "Jianfeng Group") Public Offering Corporate Bonds with Total Not Exceeding RMB .5 billion (Including .7 billion) (Below referred to as "this times bonds " ) has been approved by China securities regulatory Commission (hereinafter referred to as "China securities regulatory Commission ") securities regulatory license [2013]595 document .
This bond will be issued in installments, of which the first installment is to be issued at .7 billion yuan, that is, Zhejiang Jianfeng Group Co., Ltd. 2013 corporate bonds (the first installment) (hereinafter referred to as "current bonds").
2 , the face value of the current bond issue is RMB 30,000 yuan, each face value is RMB 100 yuan, totaling 300 , and the issue price is 100 yuan /.
3 , The current bond rating is AA + , and the main credit rating is AA ; Before the listing of this issue of bonds, the owner's equity (including minority shareholders' equity) in the consolidated statement of issuer as of 2012 # November was 164,643.81 .16 million yuan;# The asset-liability ratio of the 117 consolidated statement is 40.74 (the parent company's asset-liability ratio is 25.77 ) ; Before the current bond is listed, the average annual distributable profit realized by the issuer in the last three fiscal years is 18,836.85 .24 million yuan (taken from the average net profit attributable to the owner of the parent company in the consolidated statements of 2010 , 2011 and 2012 ) , is expected to be no less than 1.5 times of the one-year interest on this bond. The issuer's financial indicators prior to the Offering were in compliance with the relevant regulations.
5 , Current Bond by Tianjin Tianshili Group Co., Ltd. provides full unconditional and irrevocable joint and several liability guarantee .
6 , current bond is 5 -year fixed-rate bond (with 3 year-end issuer coupon rate increase option and investor resale option). The bonds bear interest on an annual basis at simple interest, without compound interest. The coupon rate shall be fixed for 3 160 years before the term of the bonds. If the issuer exercises the option to increase the coupon rate, the coupon rate for 2 years after the term of the bonds that have not been sold back shall be the coupon rate for 3 years before the term of the bonds 165 plus the increase basis point, and shall be fixed 2 years after the term of the bonds; if the issuer does not exercise the option to increase the coupon rate, the coupon rate of the portion of the bonds that have not been resold will remain unchanged at the original coupon rate for 2 years after their duration. The inquiry range of the coupon rate of the current bond is
4.60- 5.40 . The issuer and the sponsor (lead underwriter) will make an inquiry to offline institutional investors on 201 3 , , April 4 (T-1 ), and determine the final coupon rate of the bonds based on the inquiry . The issuer and the sponsor (lead underwriter) will announce the final coupon rate of the current bond on the 200 "shanghai securities news", "china securities journal" and the website of Shanghai Stock Exchange (www.sse.com.cn ) on 203 , , , , (T ). Please pay attention to it. 7 , This issue of bonds adopts a combination of online public offering to public investors and offline inquiry and placement to institutional investors
. Online subscription is completed in real time according to the principle of"time first " , and offline subscription is 215 by the issuer and the sponsor (lead underwriter) according to the inquiry. The specific issuance arrangements will be made in accordance with the relevant provisions of the Shanghai Stock Exchange . For the specific placement principles, please refer to "6 , Placing" in "4. Offline Issuance" of this announcement ". 8 , the number of bonds to be issued online and offline is 1,000 .26 million yuan and
29,000.28 million yuan respectively. The issuer and the sponsor (lead underwriter) will decide whether to start the callback mechanism according to the online issuance . If the online issuance quantity is fully subscribed, no callback will be made. If the online issuance quantity is insufficient, the remaining part will be transferred back to the offline issuance. If the offline subscription is insufficient, the undersubscribed 3 .3 billion yuan will be purchased by the lead underwriter by way of balance underwriting. This bond takes a one-way callback, not offline to online callback. 9 and Online Investors participate in the subscription through
Shanghai Stock ExchangeTrading System. The online distribution code is 751975 , which is referred to as "13 Peak 01 " . The minimum subscription unit for each securities account participating in this online issuance is 1 (10 , 1,000 yuan), and the number exceeding 1 must be an integer multiple of 1 . The number of online subscriptions is unlimited. After the issuance of this bond, the online issuance code 751975 will be converted to the listing code 122227 . 10 , Offline issuance is only for institutional investors. Institutional investors
participate in offline inquiry and subscription by submitting"Zhejiang Jianfeng Group Co., Ltd. 2013 Corporate Bonds (Phase I) Offline Interest Rate Inquiry and Application Form for Purchase" to the sponsor (lead underwriter). The minimum subscription quantity under the net is 1 (10 , 1,000 yuan), and the number exceeding 1 must be an integer multiple of 1 (I .e. 1 , 00 0 yuan). 11 . Investors shall not illegally use other people's accounts or funds to subscribe, nor shall they illegally finance or subscribe for other people. Investors who subscribe for and hold the bonds shall abide by the relevant laws and regulations and the relevant provisions of the China Securities Regulatory Commission, and bear the corresponding legal responsibilities.
12. Investors are requested to pay attention to the specific provisions of this Announcement on the issuance method, issuance object, issuance quantity, issuance time, subscription method, subscription procedure, subscription price and payment of subscription funds.
13 . The issuer will go through the relevant listing procedures as soon as possible after the issuance of the bonds, and the specific listing time will be announced separately.
14. This issue of bonds is issued to the whole market (including individual investors). After the issuance is completed, this issue of bonds is expected to be listed on the Shanghai Stock Exchange bidding trading system, block trading system and fixed income securities comprehensive electronic platform at the same time. The bond is eligible for repurchase and can enter the pledge library for repurchase transactions.
1 5 , this Announcement only explains matters related to the issuance of the bonds and does not constitute any investment advice for the bonds. For investors to learn more about the issuance of bonds in this issue, please carefully read the prospectus of
Zhejiang Jianfeng GroupCo., Ltd. public offering of corporate bonds (Phase I) . For information about this issue, investors can also go to the website of Exchange (http://www.sse. com. cn ) on . 1 6 . For other matters related to the issuance of this issue of bonds, the issuer and sponsor (lead underwriter) will make timely announcements on the website of shanghai securities news, china securities journal and Shanghai Exchange (
http://www.sse.com. cn ) as necessary. Please pay attention to investors. Interpretation Meaning
Unless otherwise stated, the following abbreviations have the following meanings in thisAnnouncement :
Issuer,
Jianfeng GroupRefers to |
Zhejiang Jianfeng Group Co., Ltd. |
Current Bond |
| Refers |
Zhejiang Jianfeng Group Co., Ltd. 201 3 Corporate Bonds | (Phase I)
This Issue |
| refers to the Issue of |
Bonds |
|
More information
The company fully deploys 2018 work
On January 27, the group company held a business analysis meeting to review and summarize the work in 2017, arrange and deploy the work for the new year, and put forward work requirements. At the meeting, various professional companies and directly affiliated enterprises reported on the overall work situation in 2017, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2018. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the "three reductions and three improvements" and the safety and environmental protection work in 2017. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of its subordinate enterprises. The functional departments and offices of the headquarters also made a brief report on their annual work. Yu Jianhong, general manager of the group company, made a comprehensive review of the company's operation in 2017, compared and analyzed the main economic indicators of various industrial sectors, and pointed out that looking for new investment and development projects around strategic objectives, promoting the optimization of organizational structure and post setting, significantly improving the level of information management, improving the ability of fund management and tax planning, achieving certain results in scientific and technological innovation and technological transformation, and strengthening marketing management and market expansion, safety and environmental protection work is basically up to standard, training and talent development have achieved new results and other work highlights; at the same time, it summarizes and reflects on the shortcomings in strategic decision-making, management innovation, performance appraisal, market operation, and talent team building. After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong informed
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-30
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
Jianfeng Pharmaceutical was rated as a provincial trademark brand demonstration enterprise
On December 28, 2017, Zhejiang Administration for Industry and Commerce announced the list of trademark brand demonstration counties (cities, districts), demonstration towns (streets) and demonstration enterprises in Zhejiang Province in 2017. Jianfeng Pharmaceutical Company was identified as a trademark brand demonstration enterprise, and it was also the only enterprise in Jinhua City to enter the list. Peak Pharmaceutical was established in 1998 and obtained the first registered trademark in 1999. Since then, Jianfeng Pharmaceutical has been actively carrying out brand building in accordance with the requirements of the Trademark Law and other laws and regulations, and has set up an intellectual property department to carry out trademark management, rights protection and other activities; it has established a sound trademark management system, strictly in accordance with the provisions of the Trademark Law to supervise and manage the use of trademarks inside and outside the enterprise, and safeguard the legitimate rights and interests of the enterprise. Establish strategic cooperation with professional institutions, for trademark applications, renewals and other work. In recent years, Jianfeng Pharmaceutical has also explored trademark investment, creating value through intangible assets such as trademarks and brands, promoting efficiency improvement, and further expanding corporate influence; at the same time, it has continuously increased investment in new product research and development and technological transformation, and actively Declare various patents to provide strong support for brand building with technological innovation. According to incomplete statistics, Jianfeng Pharmaceutical and its subsidiaries currently have more than 120 valid trademarks, including 1 well-known trademark in China, 2 well-known trademarks in Zhejiang Province, 5 well-known trademarks in Jinhua City, and 2 overseas registered trademarks; Obtained more than 40 domestic and international patents. Trademark is an important part of intellectual property rights, in the knowledge economy, brand effect is increasingly becoming the leading force of economic development.
2020
07-31
Peak Pharmaceutical Invests in Shanghai North Carolina to Build API R & D and Production Base
News from our newspaper On January 19, the group company held the second meeting of the tenth board of directors and reviewed and approved the "Proposal on Foreign Investment of Subsidiary Jianfeng Pharmaceutical." On the same day, Jianfeng Pharmaceutical signed an agreement to invest in Shanghai North Carolina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Shanghai North Carolina") by acquiring shares and increasing capital. Shanghai Beika is a high-tech enterprise in Shanghai. It has an academician expert workstation and a number of Shanghai high-tech achievements transformation projects. It has won the title of "second prize for scientific and technological progress" in Songjiang District, Shanghai, "patent pilot enterprise" and "enterprise technology center" in Songjiang District, Shanghai. The company has strong research and development capabilities and has obtained 14 patents. At present, its main business is to provide products and customized services for domestic and foreign pharmaceutical companies. The products mainly include Tinib, alkaloids, carbohydrates and other anti-tumor drug intermediates. The customized services are mainly CDMO (contract development and manufacturing) of new drugs and intermediates. Shanghai North Carolina has two wholly-owned subsidiaries, Anhui Changtai Chemical Co., Ltd. (hereinafter referred to as "Changtai Chemical") and Anhui North Carolina Pharmaceutical Co., Ltd. (hereinafter referred to as "Anhui North Carolina"). Changtai Chemical is a pesticide manufacturer designated by the Ministry of Industry and Information Technology. It was established in July 2007. It now has three chemical synthesis workshops and a pesticide preparation compounding workshop, with 10 product approvals and 13 patents. Anhui North Carolina was established in December 2016. Its business scope includes the customization, production and sales of chemical raw materials and pharmaceutical intermediates, and the wholesale and retail of chemical raw materials and products (except hazardous chemicals
2020
07-31
The company was rated as an advanced unit of the city's focus on talent and love talent.
News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)
2020
07-31